Camtek Ltd. $CAMT Shares Acquired by Phoenix Financial Ltd.

Phoenix Financial Ltd. boosted its position in Camtek Ltd. (NASDAQ:CAMT) by 746.3% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,013,214 shares of the semiconductor company’s stock after buying an additional 1,775,319 shares during the quarter. Camtek makes up about 2.1% of Phoenix Financial Ltd.’s portfolio, making the stock its 13th biggest position. Phoenix Financial Ltd. owned about 4.31% of Camtek worth $311,938,000 at the end of the most recent reporting period.

Several other institutional investors have also recently bought and sold shares of the company. Migdal Insurance & Financial Holdings Ltd. boosted its position in Camtek by 15.6% during the 3rd quarter. Migdal Insurance & Financial Holdings Ltd. now owns 3,060,896 shares of the semiconductor company’s stock worth $475,204,000 after acquiring an additional 412,500 shares during the last quarter. Ashton Thomas Private Wealth LLC grew its stake in shares of Camtek by 12.3% during the 3rd quarter. Ashton Thomas Private Wealth LLC now owns 1,763 shares of the semiconductor company’s stock worth $274,000 after acquiring an additional 193 shares in the last quarter. Associated Banc Corp acquired a new stake in shares of Camtek in the third quarter valued at approximately $211,000. QRG Capital Management Inc. acquired a new stake in shares of Camtek in the second quarter valued at approximately $206,000. Finally, Whetstone Capital Advisors LLC acquired a new stake in shares of Camtek in the second quarter valued at approximately $294,000. Institutional investors own 41.93% of the company’s stock.

Key Stories Impacting Camtek

Here are a few of the latest stories about CAMT:

• Positive Sentiment: Northland Securities raised its 2027 EPS forecast to $4.72 from $4.60, increasing estimates for several 2027 quarters as well. Northland Securities estimate changes
• Neutral Sentiment: Recent coverage highlighted Camtek’s record third-quarter results and growth outlook, but framed 2027 as an execution test: the company will need to convert its outlook into sustained results. Camtek stock faces 2027 execution test after record Q3
• Negative Sentiment: Polen International Small Cap Fund reported exiting its Camtek position among its third-quarter portfolio moves. The sale may add to concerns about investor appetite, though it reflects one fund’s decision. Polen fund portfolio moves

Camtek Stock Performance

Shares of NASDAQ CAMT traded down $3.69 during midday trading on Friday, hitting $101.73. 329,075 shares of the company’s stock were exchanged, compared to its average volume of 575,690. The company has a quick ratio of 5.18, a current ratio of 5.85 and a debt-to-equity ratio of 0.65. The company’s 50 day moving average price is $133.81 and its 200 day moving average price is $155.04. Camtek Ltd. has a 12 month low of $89.13 and a 12 month high of $215.99. The firm has a market capitalization of $4.75 billion, a PE ratio of 38.53, a price-to-earnings-growth ratio of 1.56 and a beta of 1.69.

Camtek (NASDAQ:CAMT) last released its quarterly earnings data on Wednesday, November 4th. The semiconductor company reported $0.99 EPS for the quarter, meeting the consensus estimate of $0.99. The firm had revenue of $161.29 million for the quarter, compared to the consensus estimate of $160.36 million. Camtek had a net margin of 24.56% and a return on equity of 21.38%. The company’s quarterly revenue was up 28.0% on a year-over-year basis. During the same period in the previous year, the company earned $0.82 earnings per share. As a group, analysts predict that Camtek Ltd. will post 3.24 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on CAMT. Morgan Stanley lowered shares of Camtek from an “equal weight” rating to an “underweight” rating and cut their price objective for the stock from $152.00 to $126.00 in a research report on Monday, November 2nd. Stifel Nicolaus set a $140.00 target price on shares of Camtek in a research report on Wednesday, November 4th. Needham & Company LLC decreased their target price on shares of Camtek from $170.00 to $130.00 and set a “buy” rating for the company in a research report on Wednesday, November 4th. Cantor Fitzgerald reiterated a “neutral” rating and issued a $175.00 price target on shares of Camtek in a research note on Tuesday, September 22nd. Finally, B. Riley Financial cut their price target on shares of Camtek from $166.00 to $138.00 and set a “buy” rating on the stock in a research report on Monday, November 9th. Seven research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $164.00.

Insider Activity at Camtek

In related news, VP Orit Geva-Dvash sold 508 shares of Camtek stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $175.00, for a total transaction of $88,900.00. Following the completion of the sale, the vice president owned 5,205 shares of the company’s stock, valued at approximately $910,875. The trade was a 8.89% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 79.40% of the company’s stock.

About Camtek

Camtek Ltd. develops, manufactures and sells inspection and metrology equipment used in semiconductor manufacturing. Its systems help manufacturers detect defects and measure features on wafers and other components, supporting quality control as semiconductor devices become smaller and more complex. The company’s products serve applications including advanced packaging, memory, image sensors and other semiconductor processes. Camtek combines optical inspection hardware with software to analyze production data and identify issues during manufacturing.